Back to Search
DR. DAVID A RINALDI M.D.
M.D.
Hematology & Oncology Physician
NPI: 1649241746Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
11146R(LA)
Research & Publications (20)
A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma.
PMID 12216095·Cancer·2002
3-trial
Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2).
PMID 12393998·Am J Clin Oncol·2002
3-trial
A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3).
PMID 11458814·Cancer Invest·2001
3-trial
A phase I trial of gemcitabine and infusional 5-fluorouracil (5-FU) in patients with refractory solid tumors: Louisiana Oncology Associates protocol no. 1 (LOA-1).
PMID 10683085·Am J Clin Oncol·2000
3-trial
Unexpected absence of correlation between the genetic mechanisms regulating beta-carboline-induced seizures and anxiety manifested in an elevated plus-maze test.
PMID 11682107·Behav Brain Res·2001
4-observational
Growth assessment of paediatric patients with CF comparing different auxologic indicators: A multicentre Italian study.
PMID 19543116·J Pediatr Gastroenterol Nutr·2009
4-observational
High sensibility to reactivation by acidic lipids of the recombinant human plasma membrane Ca2+-ATPase isoform 4xb purified from Saccharomyces cerevisiae.
PMID 18822268·Biochim Biophys Acta·2008
8-other
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer.
PMID 18728662·Br J Cancer·2008
3-trial
Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
PMID 18512224·Cancer·2008
3-trial
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
PMID 18202422·J Clin Oncol·2008
3-trial
Treatment of elderly non-small cell lung cancer patients with three different schedules of weekly paclitaxel in combination with carboplatin: subanalysis of a randomized trial.
PMID 17409863·J Thorac Oncol·2006
3-trial
Theoretical studies of the hydroxide-catalyzed P-O cleavage reactions of neutral phosphate triesters and diesters in aqueous solution: examination of the changes induced by H/Me substitution.
PMID 16853939·J Phys Chem B·2005
8-other
Long-range electrostatic interactions in hybrid quantum and molecular mechanical dynamics using a lattice summation approach.
PMID 16008458·J Chem Phys·2005
8-other
To give or to receive? Opinions of teenagers on kidney donation.
PMID 15110553·Transplant Proc·2004
8-other
Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma.
PMID 14770430·Cancer·2004
3-trial
Efficacy of an educational program on dialysis, renal transplantation, and organ donation on the opinions of high school students: a randomized controlled trial.
PMID 15110545·Transplant Proc·2004
3-trial
How many organs should one patient receive? The ethics of transplantation in the medical school.
PMID 15110551·Transplant Proc·2004
8-other
Kidney vending: opinions of the medical school students on this controversial issue.
PMID 15110552·Transplant Proc·2004
8-other
A self-consistent reaction field model of solvation using distributed multipoles. I. Energy and energy derivatives.
PMID 15268373·J Chem Phys·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4809 AMBASSADOR CAFFERY PKWY, SUITE 110
LAFAYETTE, LA 70508 - Phone
- (337) 235-7898
Quick Facts
- NPI
- 1649241746
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile